Login / Signup

A cluster-randomized, placebo-controlled trial to evaluate the efficacy of a spatial repellent (Mosquito Shield™) against Aedes-borne virus infection among children ≥ 4-16 years of age in the Gampaha District, Sri Lanka: study protocol (the AEGIS program).

Hasitha TisseraD S Anoja F DheerasingheNeelika MalavigeH Asita de SilvaAmy C MorrisonThomas W ScottRobert C ReinerJohn P GriecoNicole L Achee
Published in: Trials (2023)
gov NCT05452447 . Registered on July 11, 2022. The Universal Trial Number is U1111-1275-3055.
Keyphrases
  • study protocol
  • double blind
  • aedes aegypti
  • phase iii
  • placebo controlled
  • open label
  • clinical trial
  • dengue virus
  • phase ii
  • randomized controlled trial
  • zika virus
  • quality improvement
  • south africa